4//SEC Filing
Bourdon David 4
Accession 0001209191-22-000949
CIK 0000019411other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:02 PM ET
Size
13.5 KB
Accession
0001209191-22-000949
Insider Transaction Report
Form 4
Bourdon David
Chief Financial Officer
Transactions
- Disposition to Issuer
Restricted Stock Units
2022-01-04−4,383→ 0 totalExercise: $0.00→ Common Stock (4,383 underlying) - Disposition to Issuer
Restricted Stock Units
2022-01-04−16,963→ 0 totalExercise: $0.00→ Common Stock (16,963 underlying) - Disposition to Issuer
Performance-Based Restricted Stock Units
2022-01-04−4,362→ 0 totalExercise: $0.00→ Common Stock (4,362 underlying) - Disposition to Issuer
Ordinary Common Stock, $0.01 par value
2022-01-04−1,330→ 0 total
Footnotes (5)
- [F1]In connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among the Issuer, Centene Corporation ("Centene") and Mayflower Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Centene, each share of the Issuer's common stock, par value $0.01 per share (the "Common Stock") outstanding immediately prior to the effective time of the Merger and not otherwise excluded pursuant to the terms of the Merger Agreement was disposed of in exchange for $95.00 per share in cash, without interest (the "Merger Consideration").
- [F2]Not applicable.
- [F3]These unvested restricted stock units previously granted by the Issuer on October 1, 2020, which provided for vesting in equal increments on each of October 1, 2022 and 2023, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement.
- [F4]These unvested restricted stock units previously granted by the Issuer on March 3, 2021, which provided for a one-third vesting of shares on each of March 3, 2022, 2023 and 2024, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement.
- [F5]These performance-vested restricted stock units of the Issuer that were previously reported in connection with an award granted on October 1, 2020 were disposed of in exchange for a number of time-vested restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement.
Documents
Issuer
MAGELLAN HEALTH INC
CIK 0000019411
Entity typeother
Related Parties
1- filerCIK 0001823690
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:02 PM ET
- Size
- 13.5 KB